FDA Inspection 1102004 — Laboratoire Icare
The FDA completed an inspection of Laboratoire Icare on August 2, 2019 in Saint-Beauzire. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 2, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint-Beauzire (France)